HindustanTimes Fri,29 Aug 2014

Ranbaxy slumps, Sun Pharma surges on $3.2-billion acquisition

Reuters  Mumbai, April 07, 2014
First Published: 09:36 IST(7/4/2014) | Last Updated: 10:20 IST(7/4/2014)

Shares in India's Ranbaxy Laboratories Ltd fell as much as 3.2% on profit-taking after Sun Pharmaceutical Industries Ltd said it will buy the company in a $3.2 billion all-share deal, creating the world's fifth-largest generic drug maker.

Ranbaxy shares had surged 32.6 % in six consecutive sessions of gains till Friday's close.

Sun Pharmaceutical shares rose as much as 4 %.

Under terms of the agreed deal, Ranbaxy shareholders will get 0.8 of a Sun Pharmaceutical share for each Ranbaxy share they own. Daiichi Sankyo said in a statement that it will hold a stake of about 9 % in Sun Pharmaceutical after the deal.

more from Business

Former Infosys executives Bala, Pai plan $100mn global tech fund

Former Infosys board members and chief financial officers TV Mohandas Pai and V Balakrishnan are planning a $100-million (Rs 600-crore) offshore venture fund to invest in technology startups worldwide.
Most Popular
Copyright © 2014 HT Media Limited. All Rights Reserved